Migraine and Epilepsy in Children: A Narrative Review of Comorbidity and Similar Treatment Option

Ali Akbar Momen1, Gholamreza Jelodar1, Reza Azizimalamiri1

  • 1Department of Pediatric Neurology, Golestan Medical, Educational, and Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Insights

Pediatric migraine and epilepsy share similarities in symptoms and treatments. Interventions for epilepsy, including medications and lifestyle changes, may also benefit migraine prevention, warranting further research.

Area of Science:

  • Neurology
  • Pediatrics

Background:

  • Migraine and epilepsy are chronic neurological disorders with overlapping clinical features.
  • Pediatric migraine and epilepsy present unique challenges in diagnosis and management.

Purpose of the Study:

  • To review and highlight the similarities between pediatric migraine and epilepsy.
  • To explore shared epidemiological, pathophysiological, genetic, and clinical aspects.
  • To assess the potential of epilepsy treatments for migraine prevention.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of clinical features, pathophysiology, genetics, and pharmacology.
  • Evaluation of pharmacological and non-pharmacological interventions.

Main Results:

  • Shared clinical features and potential treatment overlaps exist between pediatric migraine and epilepsy.
  • Pharmacological profiles of prophylactic medications for both conditions are similar.
  • Non-pharmacological interventions like ketogenic diet and vagal nerve stimulation show promise for both disorders.

Conclusions:

  • Further research is crucial to elucidate the underlying pathophysiological and genetic links.
  • Epilepsy interventions may offer novel therapeutic strategies for migraine prevention.
  • Randomized controlled trials are urgently needed to validate these therapeutic approaches.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
331
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
186
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
316
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
284
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
165
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31